Randomized Double-Blind Placebo-Controlled Crab or Shrimp Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques
Status
Conditions
Treatments
Details and patient eligibility
About
Purpose of this study is to determine whether NAET procedures are effective in the treatment of crab or shrimp allergy.
Hypothesis: experimental group will show a significant improvement over the control group in allergic symptom, serum crab- or shrimp-specific IgE and skin test for crab or shrimp extract.
Full description
Nambudripad allergy elimination techniques (NAET) were developed by Dr. Devi Nambudripad in 1983. Many patients have been relieved of allergy and allergy-related disease by this treatment.
Lack of well-controlled clinical study prevents NAET from being accepted as a treatment option in current medical system.
The aim of this project is to conduct a double blind-placebo controlled study of applying NAET to treat crab or shrimp allergy.
The parameters to be measured are allergic symptom, crab- or shrimp-specific IgE and skin test before and after NAET treatment
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Older or equal to 20 years old
- History of allergic to crab or shrimp
- Positive serum crab- or shrimp-specific IgE
Exclusion criteria
- History of anaphylactic shock
- On medication of anti-histamine or steroid
- Pregnancy
Trial design
Primary purpose
Allocation
Interventional model
Masking
80 participants in 2 patient groups, including a placebo group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal